NCT04369703View on ClinicalTrials.gov

Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery

CompletedOBSERVATIONAL

Enrollment

199

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

April 29, 2022

Study Completion Date

April 29, 2022

Conditions

Sellar and Suprasellar MassesPituitary Tumor

Trial Locations (1)

55901

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER